Gla-Rich Protein, Magnesium and Phosphate Associate with Mitral and Aortic Valves Calcification in Diabetic Patients

Ana P Silva1,2, Carla S B Viegas3,4, Patrícia Guilherme5

  • 1Department of Nephrology, Centro Hospitalar Universitário do Algarve, 8000-386 Faro, Portugal.

Insights

Low Gla-rich protein (GRP) levels are linked to heart valve calcification in chronic kidney disease (CKD) patients. This finding suggests GRP may aid in early cardiovascular risk assessment for CKD individuals.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Cardiovascular calcification, particularly valvular calcification (VC), is prevalent and a significant mortality predictor in chronic kidney disease (CKD) patients.
  • Early diagnosis of VC is challenging due to a lack of validated biomarkers.
  • Gla-rich protein (GRP) is identified as a potential inhibitor of cardiovascular calcification.

Purpose of the Study:

  • To investigate the association between serum Gla-rich protein (GRP) levels and the presence of mitral and aortic valve calcification (VC) in diabetic patients with CKD stages 2-4.
  • To evaluate GRP as a potential diagnostic biomarker for VC in this high-risk population.

Main Methods:

  • A cohort of 80 diabetic patients with CKD stages 2-4 was studied.
  • Serum GRP levels were measured and correlated with the presence of mitral and aortic valve calcification.
  • Statistical analyses, including univariate, multivariate, and Poisson regression, were performed, alongside Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

  • Valvular calcification (VC) was detected in 36.2% (mitral) and 34.4% (aortic) of patients.
  • Lower serum GRP levels were significantly associated with both mitral and aortic VC, independent of age and gender.
  • Low GRP and magnesium (Mg), and high phosphate (P) levels were associated with VC. GRP demonstrated higher diagnostic value (AUC for mitral: 0.762, aortic: 0.802) compared to Mg and P.

Conclusions:

  • Low serum GRP levels, along with low magnesium and high phosphate, are independent and cumulative risk factors for valvular calcification (VC) in diabetic CKD patients.
  • GRP shows potential as a useful biomarker for cardiovascular risk assessment in this population.
  • Further research is warranted to validate GRP's role in predicting VC and cardiovascular outcomes in CKD.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
95
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
146
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
134
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
101